Have a personal or library account? Click to login
Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis Cover

Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis

Annals of Global Health
Volume 88 (2022): Issue 1
By: Elochukwu Fortune Ezenwankwo,  Daniel A. Nnate,  Catherine Adebukola Oladoyinbo,  Hassan Mohammed Dogo,  Ademola Amos Idowu,  Chimdimma Peace Onyeso,  Chidiebere Ndukwe Ogo,  Motolani Ogunsanya,  Olufikayo Bamidele and  Chukwudi A. Nnaji  
Open Access
|May 2022

References

  1. 1Katz EG, Stensland KD, Mandeville JA, et al. Triaging Office Based Urology Procedures during the COVID-19 Pandemic. The Journal of Urology. 2020; 204: 9–10. DOI: 10.1097/JU.0000000000001034
    Back to article
  2. 2Ribal MJ, Cornford P, Briganti A, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. European Urology. 2020; 78: 21–28. DOI: 10.1016/j.eururo.2020.04.056
    Back to article
  3. 3Kokorovic A, So AI, Hotte SJ, et al. A canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the canadian urologic oncology group and the canadian urological association. Canadian Urological Association Journal. 2020; 14: 163–168. DOI: 10.5489/cuaj.6667
    Back to article
  4. 4Obek C, Doganca T, Argun OB, Kural AR. Management of prostate cancer patients during COVID-19 pandemic. Prostate Cancer and Prostatic Diseases. 2020; 23: 398–406. DOI: 10.1038/s41391-020-0258-7
    Back to article
  5. 5Bolenz C, Vogel T, Morakis P, et al. Urologic cancer care during the first wave of the COVID-19 pandemic: Role of federal cancer registration in Germany. Urologe. 2021; 60: 291–300. DOI: 10.1007/s00120-021-01454-3
    Back to article
  6. 6Phé V, Karsenty G, Robert G, et al. Widespread Postponement of Functional Urology Cases During the COVID-19 Pandemic: Rationale, Potential Pitfalls, and Future Consequences. European Urology. 2020; 78: 4–5. DOI: 10.1016/j.eururo.2020.04.031
    Back to article
  7. 7Fallara G, Sandin F, Styrke J, et al. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scandinavian Journal of Urology. 2021; 55: 184–191. DOI: 10.1080/21681805.2021.1910341
    Back to article
  8. 8Pepe P, Pepe L, Pennisi M, Fraggetta F. Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic. Anticancer Research. 2021; 41: 3127–3130. DOI: 10.21873/anticanres.15097
    Back to article
  9. 9Oderda M, Roupret M, Marra G, et al. The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead? European Urology. 2020; 78: 124–126. DOI: 10.1016/j.eururo.2020.04.036
    Back to article
  10. 10Seraphin TP, Joko-Fru WY, Hämmerl L, et al. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 2021; 127: 4221–4232. DOI: 10.1002/cncr.33818
    Back to article
  11. 11Nnaji CA, Moodley J. Impact of the COVID-19 pandemic on cancer diagnosis, treatment and research in African health systems: A review of current evidence and contextual perspectives. Ecancermedicalscience. 2021; 15. DOI: 10.3332/ecancer.2021.1170
    Back to article
  12. 12Ezenwankwo EF, Nnaji CA. Prostate cancer and the added burden of COVID-19 in sub-Saharan Africa: Rethinking regional priorities for responsive and data-driven cancer control programs. Cancer. 2021; 127: 4711–4712. DOI: 10.1002/cncr.33887
    Back to article
  13. 13Greenberg SA, Washington SL. The state of our understanding of prostate cancer in sub-Saharan Africa. Cancer. 2021; 127: 4131–4132. DOI: 10.1002/cncr.33815
    Back to article
  14. 14Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021; 71: 209–249. DOI: 10.3322/caac.21660
    Back to article
  15. 15Rebbeck TR, Devesa SS, Chang B-L, et al. Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent. Prostate Cancer. 2013; 1–12. DOI: 10.1155/2013/560857
    Back to article
  16. 16Cook MB, Wang Z, Yeboah ED, et al. A genome-wide association study of prostate cancer in West African men. Human genetics. 2014; 133: 509–521. DOI: 10.1007/s00439-013-1387-z
    Back to article
  17. 17Ricks-Santi LJ, Apprey V, Mason T, et al. Identification of genetic risk associated with prostate cancer using ancestry informative markers. Prostate Cancer and Prostatic Diseases. 2012; 15: 359–364. DOI: 10.1038/pcan.2012.19
    Back to article
  18. 18Ahmed RO, Sewram V, Oyesegun AR, et al. A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men. African Journal of Urology: The Official Journal of the Pan African Urological Surgeons’ Association (PAUSA). 2022; 28: 6. DOI: 10.1186/s12301-022-00273-y
    Back to article
  19. 19Johnson JR, Woods-Burnham L, Hooker SE, et al. Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent. Frontiers in Oncology. 2021; 11: 770500. DOI: 10.3389/fonc.2021.770500
    Back to article
  20. 20Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68: 394–424. DOI: 10.3322/caac.21492
    Back to article
  21. 21McPhail S, Swann R, Johnson SA, et al. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study. The Lancet Oncology; 2022. DOI: 10.1016/S1470-2045(22)00127-9
    Back to article
  22. 22Kyei MY, Adusei B, Klufio GO, et al. Treatment of localized prostate cancer and use of nomograms among urologists in the West Africa sub-region. The Pan African Medical Journal. 2020; 36: 1–8. DOI: 10.11604/pamj.2020.36.251.21419
    Back to article
  23. 23Asamoah FA, Yarney J, Awasthi S, et al. Contemporary Radiation Treatment of Prostate Cancer in Africa: A Ghanaian Experience. Journal of Global Oncology. 2018; 4: 1–13. DOI: 10.1200/JGO.17.00234
    Back to article
  24. 24Bamidele O, McGarvey H, Lagan BM, et al. Life after prostate cancer: A systematic literature review and thematic synthesis of the post-treatment experiences of Black African and Black Caribbean men. European Journal of Cancer Care. 2018; 27. DOI: 10.1111/ecc.12784
    Back to article
  25. 25Ezenwankwo EF, Oladoyimbo CA, Dogo HM, et al. Factors Influencing Help-Seeking Behavior in Men with Symptoms of Prostate Cancer: A Qualitative Study Using an Ecological Perspective. Cancer Investigation; 2021. DOI: 10.1080/07357907.2021.1933009
    Back to article
  26. 26Cassell A, Yunusa B, Jalloh M, et al. A Review of Localized Prostate Cancer: An African Perspective. World Journal of Oncology. 2019; 10: 162. DOI: 10.14740/wjon1221
    Back to article
  27. 27Lewis S, Gurram L, Velu U, Sharan K. Triaging and adaptations of surveillance of cancer services in the COVID pandemic. Journal of Radiotherapy in Practice. 2020; 1–3. DOI: 10.1017/S1460396920001004
    Back to article
  28. 28Kugbey N, Ohene-Oti N, Vanderpuye V. COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study. Ecancermedicalscience. 2020; 14. DOI: 10.3332/ecancer.2020.ed99
    Back to article
  29. 29Villain P, Carvalho AL, Lucas E, et al. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group. International Journal of Cancer. 2021; 149: 97–107. DOI: 10.1002/ijc.33500
    Back to article
  30. 30World Health Organization (WHO). GUIDE TO CANCER EARLY DIAGNOSIS. 2017; https://apps.who.int/iris/handle/10665/254500. License: CC BY-NC-SA 3.0 IGO.
    Back to article
  31. 31Hale S, Grogan S, Willott S. Patterns of self-referral in men with symptoms of prostate disease. British Journal of Health Psychology. 2007; 12: 403–419. DOI: 10.1348/135910706X118413
    Back to article
  32. 32Nelson B. When religion opens the door: Despite the challenges, partnerships with religious and spiritual communities can address medical disparities and improve patients’ wellbeing. Cancer Cytopathology. 2017; 125: 885–886. DOI: 10.1002/cncy.21954
    Back to article
  33. 33Stevens C, Bondy SJ, Loblaw DA. Wait times in prostate cancer diagnosis and radiation treatment. Journal of the Canadian Urological Association. 2010; 4: 243–248. DOI: 10.5489/cuaj.09122
    Back to article
  34. 34Gasnier A, Parvizi N. Updates on the diagnosis and treatment of prostate cancer. British Journal of Radiology. 2017; 90. DOI: 10.1259/bjr.20170180
    Back to article
  35. 35Chen FZ, Zhao XK. Prostate cancer: Current treatment and prevention strategies. Iranian Red Crescent Medical Journal. 2013; 15: 279–284. DOI: 10.5812/ircmj.6499
    Back to article
  36. 36Ajape A, Ibrahim KOO, Fakeye JA, Abiola OO. An overview of cancer of the prostate diagnosis and management in Nigeria: The experience in a Nigerian tertiary hospital. Annals of African Medicine. 2010; 9: 113–117. DOI: 10.4103/1596-3519.68353
    Back to article
  37. 37Ayandipo O, Wone I, Kenu E, et al. Cancer ecosystem assessment in West Africa: Health systems gaps to prevent and control cancers in three countries: Ghana, Nigeria and Senegal. Pan African Medical Journal. 2020; 35. DOI: 10.11604/pamj.2020.35.90.18516
    Back to article
  38. 38Adeyemi OF, Mghari R. First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125. African Journal of Urology. 2020; 26: 1–6. DOI: 10.1186/s12301-020-00098-7
    Back to article
  39. 39Leng J, Ntekim AI, Ibraheem A, et al. Infrastructural challenges lead to delay of curative radiotherapy in Nigeria. Journal of Global Oncology. 2020; 6: 269–276. DOI: 10.1200/JGO.19.00286
    Back to article
  40. 40Chambers SK, Schover L, Nielsen L, et al. Couple distress after localised prostate cancer. Supportive Care in Cancer. 2013; 11(21): 2967–2976. DOI: 10.1007/s00520-013-1868-6
    Back to article
  41. 41MA H, AL S, MR I, KS T. Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association. 2013; 32: 66–74. DOI: 10.1037/a0030020
    Back to article
  42. 42Salter KL, Kothari A. Using realist evaluation to open the black box of knowledge translation: A state-of-the-art review. Implementation Science. 2014; 9: 1–14. DOI: 10.1186/s13012-014-0115-y
    Back to article
  43. 43Greenhalgh J, Manzano A. Understanding ‘context’ in realist evaluation and synthesis. DOI: 10.1080/13645579.2021.1918484
    Back to article
  44. 44De Weger E, Van Vooren NJE, Wong G, et al. What’s in a Realist Configuration? Deciding Which Causal Configurations to Use, How, and Why. International Journal of Qualitative Methods. 2020; 19. DOI: 10.1177/1609406920938577
    Back to article
  45. 45Gilmore B, McAuliffe E, Power J, Vallières F. Data Analysis and Synthesis Within a Realist Evaluation: Toward More Transparent Methodological Approaches. 2019; 18. DOI: 10.1177/1609406919859754
    Back to article
  46. 46Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist synthesis: an introduction. ESRC Research Methods Program; 2004.
    Back to article
  47. 47Sandelowski M, Voils CI, Barroso J. Defining and Designing Mixed Research Synthesis Studies. Research in the schools: A Nationally Refereed Journal Sponsored by the Mid-South Educational Research Association and the University of Alabama. 2006; 13: 29.
    Back to article
  48. 48Leask CF, Sandlund M, Skelton DA, et al. Framework, principles and recommendations for utilising participatory methodologies in the co-creation and evaluation of public health interventions. Research Involvement and Engagement. 2019; 5: 1–16. DOI: 10.1186/s40900-018-0136-9
    Back to article
  49. 49World Health Organization (WHO). Handbook for National Quality Policy and Strategy: a practical approach for developing policy and strategy to improve quality of care; 2018.
    Back to article
DOI: https://doi.org/10.5334/aogh.3519 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Published on: May 10, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Elochukwu Fortune Ezenwankwo, Daniel A. Nnate, Catherine Adebukola Oladoyinbo, Hassan Mohammed Dogo, Ademola Amos Idowu, Chimdimma Peace Onyeso, Chidiebere Ndukwe Ogo, Motolani Ogunsanya, Olufikayo Bamidele, Chukwudi A. Nnaji, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 88 (2022): Issue 1Next article